2006
DOI: 10.1227/01.neu.0000195096.43258.94
|View full text |Cite
|
Sign up to set email alerts
|

Increased Expression of 5-Lipoxygenase in High-Grade Astrocytomas

Abstract: These data indicate that 5-LO is overexpressed in high-grade astrocytomas and supports the idea that eicosanoids may play a role in tumorigenesis of these brain tumors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
20
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(26 citation statements)
references
References 32 publications
5
20
0
Order By: Relevance
“…This is consistent with previous studies on other cancer types demonstrating an association between 5-LO expression and poor survival in patients with high-grade astrocytoma, and breast cancer (4,20). Furthermore, a larger panel of data supported that the 5-LO signaling pathway exerts profound effects on human tumorigenesis and progression, and that targeting 5-LO may lead to cancer treatment or prevention (20)(21)(22)(23)(24)(25). However, the mechanism underlying how 5-LO promotes malignant transformation and malignant tumor behavior in vivo remains unclear.…”
Section: -Lo Expression Regulates Escc Cell Viability and Migration supporting
confidence: 90%
See 1 more Smart Citation
“…This is consistent with previous studies on other cancer types demonstrating an association between 5-LO expression and poor survival in patients with high-grade astrocytoma, and breast cancer (4,20). Furthermore, a larger panel of data supported that the 5-LO signaling pathway exerts profound effects on human tumorigenesis and progression, and that targeting 5-LO may lead to cancer treatment or prevention (20)(21)(22)(23)(24)(25). However, the mechanism underlying how 5-LO promotes malignant transformation and malignant tumor behavior in vivo remains unclear.…”
Section: -Lo Expression Regulates Escc Cell Viability and Migration supporting
confidence: 90%
“…Additionally, the limited in vitro data indicated that 5-LO expression induced tumor cell proliferation, whereas the knockdown of 5-LO expression suppressed tumor cell proliferation and migration. The current data indicated that 5-LO expression may serve as was observed in glioblastoma cell lines and astrocytoma tissue specimens (21). The current study demonstrated that 5-LO expression was upregulated in ESCC tissues compared with pericarcinoma tissue, and that high 5-LO expression was associated with ESCC metastasis to the regional lymph nodes and advanced pTNM stage.…”
Section: -Lo Expression Regulates Escc Cell Viability and Migration supporting
confidence: 54%
“…Because 5-LO inhibitors are cytotoxic to cancer cell lines derived from several types of malignant tumors, further research into the potential use of 5-LO inhibitors for cancer prevention and treatment is warranted. 1,15,16,38 Staining for COX-1 had a significantly lower expression than for the other observed eicosanoids, in agreement with the results of the reverse-transcriptase PCR analysis. These observations correlate with the findings of Matsuo et al, 32 who reported a weak expression of COX-1 compared to COX-2 in normal human brain tissues, meningiomas, and other brain tumors.…”
Section: Neurosurg Focus / Volume 23 / October 2007supporting
confidence: 84%
“…Nathoo and associates 38 have demonstrated 5-LO expression solely in the cytoplasm of neurons in the healthy adult brain, whereas, in most astrocytoma surgical specimens, strong staining for 5-LO was seen in the nuclei of tumor cells. The authors argued that the activation of tumor cells may lead to the translocation of 5-LO to the nuclear membrane rather than the plasma membrane; furthermore, the nuclear import…”
Section: Discussionmentioning
confidence: 98%
“…The COX1 isoform (chromosome 9) is constitutively expressed while the COX2 isoform (chromosome 1) is induced particularly in inflammatory processes. COX2 expression is up regulated in gliomas and is correlated with increasing histological grade and poor patient prognosis [27][28][29][30][31]. Clinical trials are currently under way to study the COX2 inhibitor effects on tumor progression in patients with glioblastoma multiforme GBM [32,33].…”
Section: Introductionmentioning
confidence: 99%